Lipella Pharmaceuticals Investor Relations Material

Lipella Pharmaceuticals Inc is a U.S.-based clinical-stage biopharmaceutical company focused on developing therapies for urologic and other rare diseases. The company specializes in the reformulation and delivery of existing drugs using proprietary technology to treat conditions such as interstitial cystitis, hemorrhagic cystitis, and other bladder-related disorders. Lipella conducts research and clinical trials to advance its drug candidates through regulatory pathways. The company is headquartered in Pittsburgh, Pennsylvania, and its shares are listed on the CSE.